[ad_1]
Jakarta, CNN Indonesia –
Corona vaccine Sinovac manufactured by the original pharmaceutical company China It generated criticism in several countries that ordered it. The criticism came from Brazil, the Philippines and Cambodia.
Until now, no data on the safety and efficacy (efficacy) of the third-phase clinical trial of the Sinovac vaccine are known.
This is different from Pfizer, which has released efficacy data, which is 90 percent effective, and Moderna, which claims to have an effectiveness rating of up to 94.5 percent.
In fact, the level of effectiveness is a determining element for the authorities to issue emergency use permits.
So far, the countries that have expressed their willingness to use the vaccine are Indonesia, Brazil, Turkey, Cambodia and the Philippines.
Sinovac itself has conducted clinical trials in Indonesia and Brazil.
In Indonesia, Sinovac has been conducting a third phase clinical trial since August 2020. There have been 1,620 volunteers who received the first injection and 1,610 who received the second. The clinical trial took place in Bandung, West Java.
Meanwhile, in Brazil, Sinovac is working with the Butantan Institute in Sao Paulo. The Butantan Institute is a biomedical research center and vaccine manufacturer in Brazil.
Approximately 13,000 volunteers participated in the phase 3 clinical trial. After the results of the clinical trials are announced, Brazil will begin vaccinating at the end of March.
However, efforts to use the Sinovac vaccine are not without challenges. Advantages and disadvantages of buying the vaccine have emerged.
Brazil
Brazil’s health authority Anvisa on Monday (12/14) accused Sinovac of using “non-transparent” criteria to obtain approval for the use of the CoronaVac vaccine.
“The criteria that China has applied to authorize the emergency use (of vaccines) in China are not transparent,” Anvisa said in a statement.
Anvisa, which sent a team to visit the Sinovac factory in Beijing in early December, also warned about the geopolitical impact of the vaccine.
In addition to being accused by Anvisa, Sinovac was also not saved from the grave of the conflict in Brazil. The vaccine has been the source of a dispute between President Jair Bolsonaro, the governor of Sao Paulo, Joao Doria, and the Chinese government.
Bolsonaro even disparaged the vaccine by calling it “Joao Doria’s Chinese vaccine.”
Filipina
Meanwhile, in the Philippines, the local government has come under fire from parliament for finalizing a deal to buy 25 million doses of the Sinovac vaccine.
Head of the Philippine Covid-19 Task Force, Carlito Galvez Jr. said that the acquisition of the vaccine is planned for March 2021.
Reported Philippine lifestyleOn Thursday (12/17), Senator Risa Hontiveros relayed the criticism. He said that the Philippine government should buy a vaccine that has been shown to be scientifically effective and not for political reasons.
“There are several issues surrounding the vaccines offered by China, including the disclosure of clinical trial data and results, side effects like the ones we saw in Peru, and even the company’s history of bribery,” Hontiveros said in a statement. press.
Newspaper The Washington Post He reported that the director of Sinovac admitted to having committed bribes.
In fact, Hontiveros also referred to President Rodrigo Duterte’s attitude towards China, which he often considered biased.
“Do not sacrifice the health of the Filipino people with the president’s biased attitude towards China, which continues to reject the decision of the International Court of Justice in The Hague (on property claims of the South China Sea) and violates our waters,” Hontiveros said .
Cambodia
Cambodian Prime Minister Hun Sen said his country would not use the Sinovac vaccine to vaccinate its citizens.
According to Hun Sen, his country will not accept a corona vaccine that is not certified by the World Health Organization (WHO).
Although there has been an agreement between Cambodia and China to acquire the Sinovac vaccine.
“Cambodia is not a trash can or a place for vaccine trials,” Nikkei Asia said, referring to the agreement between Cambodia and China regarding Sinovac vaccine cooperation.
So far, the WHO has not approved any vaccine candidates for Covid-19, including Sinovac.
Reported Nikkei AsiaChina is said to have pledged to support the Covid-19 vaccine effort in Cambodia, its closest ally in the region.
In August, Chinese Premier Li Keqiang told the Mekong countries that they will be given priority once a vaccine developed by China is ready for use.
This was repeated by Foreign Minister Wang Yi during a visit to Cambodia in October.
The Khmer Times On Monday it reported that the Chinese ambassador to Cambodia had contacted the government about the possible distribution of the vaccine.
Sen said his party had ordered vaccine stocks through the UN-backed COVAX facilities program. This program aims to subsidize vaccines for 92 low-income countries in the world.
The program, led by the Gavi Vaccine Alliance, will support poor countries to obtain vaccines for 20 percent of their population.
In total, Sen said his government hopes to get 26 million doses to vaccinate 13 million of its 16 million citizens for free.
Cambodia’s representative to the WHO, Li Ailan, told local media that he expects the vaccine to be available in Cambodia in early 2021 or mid-year.
(years / dea)
[Gambas:Video CNN]
[ad_2]
